Sie suchten nach: artemisinin (Englisch - Chinesisch (Vereinfacht))

artemisinin
苦艾内酯

the first evidence of artemisinin resistance was reported in western cambodia in 2008.
柬埔寨于2008年首次报告了发现青蒿素抗药性的证据。

the highly effective artemisinin derivatives and their partner drugs are vulnerable to the same risk.
高效青蒿素衍生药物及其同类药物面临同样风险。

more effective drug combinations based on artemisinin are now becoming more widely available to developing countries.
现已更广泛地向发展中国家提供较有效的青蒿素类复方药物。

43. the first evidence of plasmodium falciparum resistance to artemisinin in western cambodia was published in 2008.
43. 2008年公布了在柬埔寨西部发现的第一例恶性疟原虫疟疾对青蒿素抗药性的证据。

49. the first documented evidence of plasmodium falciparum resistance to artemisinin in western cambodia was published in 2008.
49. 2008年公布了在柬埔寨西部发现的第一例恶性疟对青蒿素抗药性的书面证据。

15. africa accounts for more than 90 per cent of the estimated global need for artemisinin-based combination therapy.
15. 在全球对青蒿素类复方疗法的估计需求量中，非洲占90%以上。

23. recent years have witnessed growing regional political commitment to address the challenge of artemisinin-resistant malaria.
23. 近年来，区域应对青蒿素耐药性疟疾的政治意愿增强。

14. artemisinin combination therapies not only are efficacious, but also help to prevent the emergence and spread of drug-resistant plasmodium.
14. 青蒿素综合疗法不仅有效，而且还有助于防止抗药性疟原虫的出现和传播。

63. information from manufacturers indicates that the number of artemisinin-based combination therapies procured has increased in every year since 2005.
63. 从制造商获得的资料表明，自2005年以来每年采购的青蒿素综合疗法药剂的数量都在增加。

a project aimed at curbing the spread of artemisinin-resistant strains was begun on the thailand-cambodia border in january 2009.
2009年1月在泰柬边界地区展开了一个遏制青蒿素抗药性菌株传播的项目。

14. artemisinin-based combination therapies not only are efficacious, but also help to prevent the emergence and spread of drug-resistant plasmodium.
14. 青蒿素综合疗法不仅有效，而且还有助于防止抗药性疟原虫的出现和传播。

40. unicef and who supported the introduction of artemisinin-based combination therapy (act) for malaria in several countries during 2004.
40. 2004年，儿童基金会和卫生组织在若干国家支持使用青蒿素综合疗法治疗疟疾。

(h) continue to prohibit the marketing of oral artemisinin monotherapies, and the cessation of funding for the procurement of oral artemisinin monotherapies by international agencies;
(h) 继续禁止销售口服青蒿素类单一疗法药物，并呼吁国际机构停止为采购口服青蒿素类单一疗法药物提供资金；

malaria control efforts in endemic countries are resulting in increased resources for scaling up control interventions including surveillance, prevention and treatment with artemisinin based combination therapies (acts).
23．在疟疾流行的国家为控制疟疾作出的努力正在使这些国家能获得更多的资源来加强控制措施，包括监测、预防和采用青蒿素综合疗法进行治疗。

43. major reasons for the limited success in the phasing-out of oral artemisinin-based monotherapies include the poor regulation of pharmaceutical markets in malaria-endemic countries.
43. 逐渐撤出青蒿素类单一疗法口服药物的工作只取得有限成绩的主要原因包括疟疾流行国家药物市场的规章不全。

11. while, initially, most artemisinins were produced in very few countries, notably viet nam and china, global production capacity has now expanded to a number of other countries.
11. 虽然大多数青蒿素最初只在为数不多的几个国家特别是越南和中国生产，但全球生产能力目前已扩大到一些其他国家。